AlzeCure Pharma (ALZCUR) — Cash Flow Reinvestment Rate

Latest as of March 2023: 0.00x

AlzeCure Pharma (ALZCUR) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting Skr7.00K (capex Skr0.00 plus investments Skr7.00K) from operating cash flow of Skr28.09 Million. Explore AlzeCure Pharma operating cash flow efficiency to assess how effectively this company generates cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr7.00K
Capex + Investments

Operating Cash Flow

Skr28.09 Million
SEK

Capital Expenditures

Skr0.00
SEK

AlzeCure Pharma Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for AlzeCure Pharma across 1 annual periods. Explore ALZCUR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for AlzeCure Pharma (2023–2023)

Year-by-year capital reinvestment analysis for AlzeCure Pharma. For live market cap and broader valuation context, see AlzeCure Pharma (ALZCUR) market capitalisation.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2023 0.00x Skr7.00K Skr3.06 Million Skr0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow